• OPEN AN ACCOUNT
Indian Indices
Nifty
24,924.70 916.70
(3.82%)
Sensex
81,148.22 -1,281.68
( -1.55%)
Bank Nifty
55,382.85 1,787.60
( 3.34%)
Nifty IT
38,282.55 2,402.45
( 6.70%)
Global Indices
Nasdaq
42,424.12 1,153.74
(2.80%)
Dow Jones
5,865.06 184.15
(3.24%)
Hang Seng
38,283.51 639.25
(1.70%)
Nikkei 225
8,604.98 50.18
(0.59%)
Forex
USD-INR
85.41 0.03
(0.03%)
EUR-INR
96.03 -0.26
(-0.27%)
GBP-INR
113.57 0.08
(0.07%)
JPY-INR
0.59 0.00
(-0.40%)

EQUITY - MARKET SCREENER

J B Chemicals & Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
506943
INE572A01036
202.8086013
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JBCHEPHARM
38.68
24315.22
EPS(TTM)
Face Value()
Div & Yield %
40.38
1
0.78
 

j b chemicals & pharmaceuticals ltd
JB Chemicals & Pharma receives USFDA approval for Bisoprolol Tablets
Apr 21,2025
The approved product is the generic version of Zebeta (marketed by Teva Pharmaceuticals) and is indicated for the management of hypertension.

JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radio-diagnostics, APIs, and intermediates.

The company's consolidated net profit jumped 21.7% to Rs 162.49 crore on a 14.1% rise in net sales to Rs 963.49 crore in Q3 FY25 over Q3 FY24.

Shares of JB Chemicals & Pharmaceuticals rose 0.47% to Rs 1,652.95 on the BSE.